Table 4.
Classification | Compound/Extract | Source | Cell Line/Animal Model | Dose; Duration | Efficacy | Mechanism | Ref. |
---|---|---|---|---|---|---|---|
Single compound | Flaccidoxide-13-acetate | Cladiella kashmani | RT4, T24 | 2.5, 5, 10 μM; 24 h | Inhibition of cell migration and invasion | ↑TIMP-1, TIMP-2 ↓MMP-2, MMP-9, uPAR, FAK, PI3K, p-PI3K, AKT, p-AKT, mTOR, p-mTOR, Rho A, Ras, MKK7, MEKK3 |
[75] |
Single compound | N-butylidenephthalide | Radix Angelica sinensis | 5637, BFTC, T24, TCCSUP | 60 μg/mL; 24 h | Inhibition of metastasis | ↑E-cadherin ↓N-cadherin |
[33] |
Single extract | Extra virgin olive oil extract (EVOO-E) | Olea europaea L. var. Itrana | T24 | 2.5, 10 μg/mL; 24 h | Inhibition of cell migration and invasion | ↑TIMP-1, TIMP-2 ↓MMP-2 |
[72] |
Single extract | Garlic extract (GE) | Allium satibum L. | EJ | 400, 600, 800 μg/mL; 24 h | Inhibition of cell migration and invasion | ↓MMP-9, AP-1, Sp-1, NF-κB | [73] |
Single extract | Sinulariolide | Sinularia flexibilis | TSGH-8301 | 800 μg/mL; 12, 24 h | Inhibition of cell migration and invasion | ↑HSPA6 | [74] |
Footer: ↑, up-regulation; TIMP, metalloproteinase; ↓, down-regulation; MMP, matrix metalloproteinase; uPAR, urokinase-type plasminogen activator receptor; FAK, focal adhesion kinase; PI3K, phosphatidylinositide-3 kinases; AKT (PKB), protein kinase B; mTOR, mammalian target of rapamycin; Rho A, Ras homolog gene family, member A; Ras, regulators of signal transduction; MKK, mitogen-activated protein kinase kinase; MEKK (MAPKKK or MAP3K), Mitogen-Activated Protein Kinase Kinase Kinase; BFTC, Black Foot disease Transitional Carcinoma; TCCSUP, isolated from an anaplastic transitional cell carcinoma (TCC) in the neck of the urinary bladder; AP, activator protein; Sp, specificity protein; NF-κB, nuclear factor kappa-light-chain-enhancer of activated B cells; TSGH, human gastric carcinoma cell line; HSPA6, Heat shock protein A6.